$360.000,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

Point-of-Care Technology for Portable Testing Devices: Nanomaterials-Based Optical Biosensors for Cardiovascular Disease Biomarkers presents the latest advances in nanomaterials-based optical biosensor-enabled point-of-care testing (PoCT) devices for the rapid and accurate detection of cardiovascular disease (CVD) biomarkers. This book begins with the introduction of novel cardiovascular biomarkers and advances in point-of-care diagnostics. Subsequent chapters focus on the selection of bioreceptors and the overview of optical nanomaterials for nanobiosensors applications.
A major focus is targeted on colorimetric detection, fluorescence, chemiluminescence, Localized Surface Plasmon Resonance, and Surface-Enhanced Raman Scattering-based optical nanobiosensor signaling readout techniques, which enable the detection of CVD biomarkers. Furthermore, this book explores emerging healthcare technologies for next-generation portable PoCT devices and recent advances in nanobiosensor techniques for the rapid detection of CVD biomarkers. One dedicated chapter explores the role of artificial intelligence in enhancing point-of-care diagnostics for CVDs, while another addresses critical regulatory challenges and safety considerations in translating nanomaterial-based biosensors into clinical practice.

  • Provides a comprehensive overview of novel CVD biomarkers and advances in point-of-care diagnostic platforms
  • Detailed exploration of bioreceptor selection and optical nanomaterials for enhancing the selectivity and sensitivity of nanobiosensors for point-of-care diagnostics
  • Explores the design and advantages of colorimetric detection, fluorescence, chemiluminescence, LSPR, and SERS-based nanobiosensors techniques, which enable rapid and portable point-of-care testing of CVD biomarkers
  • Integration of artificial intelligence to improve the precision, and efficiency of CVD diagnosis at the point-of-care
  • Addresses key regulatory, safety, and clinical translation challenges that bridge the gap between laboratory innovations and real-world healthcare applications

1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Dedication - p. v 7. List of contributors - p. xiii 8. About the editors - p. xvii 9. Foreword - p. xix 10. Preface - p. xxi 11. Acknowledgments - p. xxiii 12. Chapter 1. An overview of novel biomarkers for cardiovascular disease and advances in point-of-care diagnostics - p. 1 13. Chapter 2. Selection of bioreceptors for nanobiosensors: fundamentals and innovations in point-of-care applications - p. 27 14. Chapter 3. Comprehensive overview of optical nanomaterials: fundamentals and advantages of biosensor applications - p. 59 15. Chapter 4. Optical nanobiosensors: design, integration of binding receptors, and sensing mechanisms - p. 89 16. Chapter 5. Optical readout techniques in nanobiosensors: fundamentals and future directions for point-of-care applications - p. 119 17. Chapter 6. A visible and colorimetric nanobiosensor-based point-of-care detection of cardiovascular disease biomarkers - p. 161 18. Chapter 7. Fluorescence-based point-of-care nanobiosensors for the detection of cardiovascular disease biomarkers - p. 185 19. Chapter 8. Nanomaterials-based point-of-care chemiluminescence biosensors for the detection of cardiovascular disease biomarkers - p. 215 20. Chapter 9. Localized surface plasmon resonance-based biosensor for point-of-care detection of cardiovascular disease biomarkers - p. 251 21. Chapter 10. Surface enhanced Raman scattering based nanobiosensors for point-of-care detection of cardiovascular biomarkers - p. 279 22. Chapter 11. Emerging healthcare technologies for next-generation portable point-of-care testing devices - p. 309 23. Chapter 12. Recent advances in point-of-care nanobiosensor techniques for the rapid diagnosis of cardiovascular disease biomarkers - p. 341 24. Chapter 13. The role of artificial intelligence in point-of-care diagnosis of cardiovascular diseases - p. 369 25. Chapter 14. Regulatory and safety considerations for nanomaterial in medical and point-of-care diagnostic devices - p. 391 26. Chapter 15. Nanomaterials-based point-of-care testing devices for cardiovascular disease biomarker: advancing technologies toward clinical translation - p. 433 27. Index - p. 465

Descripcion
Descripción

Point-of-Care Technology for Portable Testing Devices: Nanomaterials-Based Optical Biosensors for Cardiovascular Disease Biomarkers presents the latest advances in nanomaterials-based optical biosensor-enabled point-of-care testing (PoCT) devices for the rapid and accurate detection of cardiovascular disease (CVD) biomarkers. This book begins with the introduction of novel cardiovascular biomarkers and advances in point-of-care diagnostics. Subsequent chapters focus on the selection of bioreceptors and the overview of optical nanomaterials for nanobiosensors applications.
A major focus is targeted on colorimetric detection, fluorescence, chemiluminescence, Localized Surface Plasmon Resonance, and Surface-Enhanced Raman Scattering-based optical nanobiosensor signaling readout techniques, which enable the detection of CVD biomarkers. Furthermore, this book explores emerging healthcare technologies for next-generation portable PoCT devices and recent advances in nanobiosensor techniques for the rapid detection of CVD biomarkers. One dedicated chapter explores the role of artificial intelligence in enhancing point-of-care diagnostics for CVDs, while another addresses critical regulatory challenges and safety considerations in translating nanomaterial-based biosensors into clinical practice.

  • Provides a comprehensive overview of novel CVD biomarkers and advances in point-of-care diagnostic platforms
  • Detailed exploration of bioreceptor selection and optical nanomaterials for enhancing the selectivity and sensitivity of nanobiosensors for point-of-care diagnostics
  • Explores the design and advantages of colorimetric detection, fluorescence, chemiluminescence, LSPR, and SERS-based nanobiosensors techniques, which enable rapid and portable point-of-care testing of CVD biomarkers
  • Integration of artificial intelligence to improve the precision, and efficiency of CVD diagnosis at the point-of-care
  • Addresses key regulatory, safety, and clinical translation challenges that bridge the gap between laboratory innovations and real-world healthcare applications

1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Dedication - p. v 7. List of contributors - p. xiii 8. About the editors - p. xvii 9. Foreword - p. xix 10. Preface - p. xxi 11. Acknowledgments - p. xxiii 12. Chapter 1. An overview of novel biomarkers for cardiovascular disease and advances in point-of-care diagnostics - p. 1 13. Chapter 2. Selection of bioreceptors for nanobiosensors: fundamentals and innovations in point-of-care applications - p. 27 14. Chapter 3. Comprehensive overview of optical nanomaterials: fundamentals and advantages of biosensor applications - p. 59 15. Chapter 4. Optical nanobiosensors: design, integration of binding receptors, and sensing mechanisms - p. 89 16. Chapter 5. Optical readout techniques in nanobiosensors: fundamentals and future directions for point-of-care applications - p. 119 17. Chapter 6. A visible and colorimetric nanobiosensor-based point-of-care detection of cardiovascular disease biomarkers - p. 161 18. Chapter 7. Fluorescence-based point-of-care nanobiosensors for the detection of cardiovascular disease biomarkers - p. 185 19. Chapter 8. Nanomaterials-based point-of-care chemiluminescence biosensors for the detection of cardiovascular disease biomarkers - p. 215 20. Chapter 9. Localized surface plasmon resonance-based biosensor for point-of-care detection of cardiovascular disease biomarkers - p. 251 21. Chapter 10. Surface enhanced Raman scattering based nanobiosensors for point-of-care detection of cardiovascular biomarkers - p. 279 22. Chapter 11. Emerging healthcare technologies for next-generation portable point-of-care testing devices - p. 309 23. Chapter 12. Recent advances in point-of-care nanobiosensor techniques for the rapid diagnosis of cardiovascular disease biomarkers - p. 341 24. Chapter 13. The role of artificial intelligence in point-of-care diagnosis of cardiovascular diseases - p. 369 25. Chapter 14. Regulatory and safety considerations for nanomaterial in medical and point-of-care diagnostic devices - p. 391 26. Chapter 15. Nanomaterials-based point-of-care testing devices for cardiovascular disease biomarker: advancing technologies toward clinical translation - p. 433 27. Index - p. 465

Indice
Autores
Muestra
Ficha Técnica